Email: "Idea: ignore drugs, they're all bs"
* In that the rate of new drug discovery is massively slowing down.  The real gains to come are in genetics.
* Another Alzheimer's IPO http://pipeline.corante.com/archives/2015/07/30/another_alzheimers_ipo.php
* Maybe a lot can be learned from failed drug studies if deep learning is applied because it doesn't sound like we know how drugs work. http://www.washingtonpost.com/news/wonkblog/wp/2015/07/23/one-big-myth-about-medicine-we-know-how-drugs-work/
* Or maybe research them differently: Generate random compounds and give them to mice.  Then monitor the mice in tons of different ways (gene expression perhaps the most comprehensive) for effects.  Then use machine learning to figure out what compounds do what.  It might point someone in the right direction if nothing else.
